About: Management of Structural Heart Disease and Acute Coronary Syndromes in the COVID-19 Pandemic

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Management of Structural Heart Disease and Acute Coronary Syndromes in the COVID-19 Pandemic Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Management of Structural Heart Disease and Acute Coronary Syndromes in the COVID-19 Pandemic
Creator	Biondi-Zoccai, Giuseppe Frati, Giacomo Bartorelli, Antonio Giordano, Arturo
Source	Medline; PMC
abstract	Transcatheter interventions for structural heart disease (SHD) now represent an effective alternative to surgery in selected patients. A clear premise is that delay in or neglect of treating patients in need of SHD intervention is associated with unavoidable morbidity and mortality because many of them have life-threatening conditions. However, the recent outbreak of coronavirus-associated disease-2019 (COVID-19) is placing an unprecedented strain on patients, physicians and world healthcare systems that resulted in deferral of elective and semi-elective procedures, such as SHD, and delay in the treatment of patients with acute coronary syndrome (ACS). We hereby present the case for a focused resumption of transcatheter SHD interventions in selected centers, in order to preserve patient safety and avoid that death rate will extend far beyond that directly associated with COVID-19. A similar approach should be applied to the invasive management of ACS. Indeed, a proactive and vigilant stance on managing SHD and ACS is crucial, especially in the context of the COVID-19 pandemic, when the risk of overlooking severely sick patients or postponing life-saving treatments is high. If such corrective measures are not put into effect, we may expect in the near future an excess of avoidable fatalities indirectly due to COVID-19 but truly caused by cardiovascular diseases, as well as an exceedingly large number of patients with severe heart failure leading to shorter life expectancy, reduced quality of life and increased healthcare cost.
has issue date	2020-06-10(xsd:dateTime)
bibo:doi	10.1007/s11883-020-00849-5
bibo:pmid	32524266
has license	no-cc
sha1sum (hex)	bcbe5df8df2a2eed9a5bb2a271d89d602ce78326
schema:url	https://doi.org/10.1007/s11883-020-00849-5
resource representing a document's title	Management of Structural Heart Disease and Acute Coronary Syndromes in the COVID-19 Pandemic
has PubMed Central identifier	PMC7283421
has PubMed identifier	32524266
schema:publication	Curr Atheroscler Rep
resource representing a document's body	covid:bcbe5df8df2a2eed9a5bb2a271d89d602ce78326#body_text
is schema:about of	named entity 'COVID-19' named entity 'proactive' named entity 'shorter' named entity 'conditions' named entity 'neglect' named entity 'patients' named entity 'risk' named entity 'vigilant' named entity 'MANAGEMENT' named entity '2019' named entity 'FOCUSED' named entity 'NEGLECT' named entity 'CONTEXT' named entity 'severe' named entity 'However' named entity 'pandemic' named entity 'COVID-19' named entity 'selected' named entity 'ACS' named entity 'morbidity' named entity 'patients' named entity 'delay' named entity 'avoid' named entity 'acute coronary syndrome' named entity 'COVID-19 pandemic' named entity 'elective procedures' named entity 'morbidity' named entity 'SHD' named entity 'SHD' named entity 'acute coronary syndrome' named entity 'heart disease' named entity 'COVID-19' named entity 'cardiovascular diseases' named entity 'Structural Heart Disease' named entity 'COVID-19' named entity 'healthcare systems' named entity 'Percutaneous' named entity 'TAVI' named entity 'work-up' named entity 'intracranial hemorrhage' named entity 'death rates' named entity 'medical therapy' named entity 'COVID-19' named entity 'symptom' named entity 'COVID-19' named entity 'prothrombotic' named entity 'heart disease' named entity 'polymerase chain reaction' named entity 'absolute risk' named entity 'acute coronary syndrome' named entity 'mitral regurgitation' named entity 'cardiovascular diseases' named entity 'MitraClip' named entity 'STEMI' named entity 'pharmacology' named entity 'aortic stenosis' named entity 'high-quality' named entity 'heart failure' named entity 'ACS' named entity 'medical therapy' named entity 'SARS-CoV-2' named entity 'transcatheter aortic valve implantation' named entity 'ACS' named entity 'COVID-19 pandemic' named entity 'severe acute respiratory syndrome' named entity 'SHD' named entity 'COVID-19' named entity 'Heart Failure' named entity 'life expectancy' named entity 'regurgitation' named entity 'mitral regurgitation' named entity 'death rate' named entity 'aortic stenosis' named entity 'SHD' named entity 'COVID-19' named entity 'TAVI' named entity 'Cardiovascular' named entity 'COVID-19'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software